Prescription medication · Nasal Corticosteroid
ciclesonide nasal
Also sold as Omnaris, Zetonna. This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older.
Data updated 2026-05-15
- 3
- InteractionsFew interactions
- $22.60
- Brand price (NADAC)
ciclesonide nasal (Omnaris) is a prescription Nasal Corticosteroid. This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older.
Omnaris Nasal Spray is a medicine that helps treat allergy symptoms in your nose. It contains a steroid that reduces inflammation.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$22.60/unit
Generic Available
No
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older.
Common side effects
Headache, Nosebleeds, Nasal passage inflammation
Key warnings
This medicine may cause nosebleeds or a Candida (fungal) infection in your nose.
The sections below are summarized in plain English from ciclesonide nasal's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Omnaris contains ciclesonide, a type of steroid. It works by reducing inflammation in your nose. This helps to relieve allergy symptoms like stuffiness and runny nose.
How to Take It
Shake the bottle gently before each use. Before you use it for the first time, prime the pump by spraying it 8 times. If you haven't used it for 4 days, re-prime it with 1 spray. The usual dose is 2 sprays in each nostril, once a day.
This is a plain-language summary of ciclesonide nasal's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Pregnancy & Breastfeeding
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if Omnaris will harm your unborn baby. Talk to your doctor if you are breastfeeding.
This is a plain-language summary of ciclesonide nasal's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.
This is a plain-language summary of ciclesonide nasal's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store at room temperature (77°F). Do not freeze. Keep out of reach of children.
Serious Warnings
This medicine may cause nosebleeds or a Candida (fungal) infection in your nose. It can also cause a hole in the wall between your nostrils, and slow wound healing in your nose. Tell your doctor if you have vision changes or a history of glaucoma or cataracts. This medicine may also hide symptoms of an infection, worsen existing infections, or slow growth in children.
Known Drug Interactions
In a drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
Mechanism: Ketoconazole slows down the process of clearing the active medicine from your system. This results in much higher levels of the drug in your body.
What to do: Use this combination with caution. Your healthcare provider may need to check for signs of increased steroid exposure.
Erythromycin, a moderate inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin following oral inhalation of ciclesonide [see Clinical Pharmacology ( 12.3 )] .
Mechanism: Studies show that erythromycin does not change the amount of medicine that stays in your body.
What to do: No dosage adjustments are necessary when using these two medications together.
7 DRUG INTERACTIONS In vitro studies and clinical pharmacology studies suggested that des-ciclesonide has no potential for metabolic drug interactions or protein binding-based drug interactions [see Clinical Pharmacology ( 12.3 )] . In a drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged. Erythromycin, a moderate inhibitor of cytochrome P450 3A4, had no effect on the...
Mechanism: This drug does not seem to change how other medicines are broken down or carried in the blood.
What to do: You generally do not need to worry about this drug causing interactions with other medications.
This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.
Common Questions
What should I do if I get a nosebleed?
Can this medicine cause infections?
How long can I use this nasal spray?
Can this medicine affect my vision?
Can children use this medicine?
What if I have a cold?
Can I use this after nasal surgery?
What does 'prime the pump' mean?
Can I use this if I'm allergic to other nasal sprays?
Does this interact with other medications?
What are the common side effects of ciclesonide nasal?
Does ciclesonide nasal interact with other medications?
What drug class is ciclesonide nasal?
Is ciclesonide nasal safe during pregnancy?
Related Medications in Nasal Corticosteroid
Other drugs grouped near ciclesonide nasal - same-class peers and common alternatives.
azelastine
Astelin, Astepro
Azelastine nasal spray is an antihistamine medicine.
Compare with ciclesonide nasal →
budesonide nasal
Rhinocort
Rhinocort is a nasal spray that helps relieve allergy symptoms.
Compare with ciclesonide nasal →
cetirizine
Zyrtec
Cetirizine (Zyrtec) is an antihistamine medicine.
Compare with ciclesonide nasal →
chlorpheniramine
Chlor-Trimeton
Chlorpheniramine is an antihistamine medicine.
Compare with ciclesonide nasal →
desloratadine
Clarinex
Desloratadine is an antihistamine medicine.
Compare with ciclesonide nasal →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on ciclesonide nasal
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for ciclesonide nasal
The FDA label for ciclesonide nasal (sold under brand names such as Omnaris, Zetonna) classifies it as a prescription-only medication in the Nasal Corticosteroid class. This medicine treats nasal symptoms from seasonal allergies in adults and kids 6 years and older. Official labeling lists 5 commonly reported side effects, including Headache, Nosebleeds, Nasal passage inflammation.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: November 8, 2022
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages